Attached files
| file | filename |
|---|---|
| 10-K/A - 10-K/A - Travere Therapeutics, Inc. | d153219d10ka.htm |
| EX-32.2 - EX-32.2 - Travere Therapeutics, Inc. | d153219dex322.htm |
| EX-31.1 - EX-31.1 - Travere Therapeutics, Inc. | d153219dex311.htm |
| EX-32.1 - EX-32.1 - Travere Therapeutics, Inc. | d153219dex321.htm |
| EX-31.2 - EX-31.2 - Travere Therapeutics, Inc. | d153219dex312.htm |
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
Retrophin, Inc.
San Diego, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (333-202861) and Form S-8 (No. 333-206510) of Retrophin, Inc. of our reports dated February 26, 2016, relating to the consolidated financial statements and the effectiveness of Retrophin, Inc.’s internal control over financial reporting, which appear in the Form 10-K filed on February 26, 2016.
/s/ BDO USA, LLP
New York, New York
February 26, 2016